Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

1 terminated/withdrawn out of 2 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2)

Showing 2 of 2 trials
NCT02128139Completed

Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study

Role: collaborator

NCT04390594Phase 3Terminated

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal

Role: collaborator

All 2 trials loaded